Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

June 01, 1995; Volume 47,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Albrightson, C R

    1. You have access
      Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;
  2. Ammon, H P

    1. You have access
      Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
      H Safayhi, E R Sailer and H P Ammon
      Molecular Pharmacology June 1995, 47 (6) 1212-1216;
  3. Arcamone, F

    1. You have access
      5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;
  4. Avenet, P

    1. You have access
      Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;

B

  1. Benchekroun, M N

    1. You have access
      Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
      M N Benchekroun, R Parker, M Dabholkar, E Reed and B K Sinha
      Molecular Pharmacology June 1995, 47 (6) 1255-1260;
  2. Biton, B

    1. You have access
      Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;
  3. Blume, R

    1. You have access
      Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.
      M Schwaninger, C Schöfl, R Blume, L Rössig and W Knepel
      Molecular Pharmacology June 1995, 47 (6) 1112-1118;
  4. Bockaert, J

    1. You have access
      Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells.
      L Fagni, M Olivier, M Lafon-Cazal and J Bockaert
      Molecular Pharmacology June 1995, 47 (6) 1239-1247;
  5. Bolos-Sy, A M

    1. You have access
      Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;
  6. Brooks, A I

    1. You have access
      Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

C

  1. Carlson, N G

    1. You have access
      N-methyl-D-aspartate receptors activate transcription of c-fos and NGFI-A by distinct phospholipase A2-requiring intracellular signaling pathways.
      L S Lerea, N G Carlson and J O McNamara
      Molecular Pharmacology June 1995, 47 (6) 1119-1125;
  2. Cheng, J

    1. You have access
      Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;
  3. Ciarrocchi, G

    1. You have access
      5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;
  4. Coffman, B L

    1. You have access
      Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
      B L Coffman, M D Green, C D King and T R Tephly
      Molecular Pharmacology June 1995, 47 (6) 1101-1105;
  5. Covey, D F

    1. You have access
      Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;

D

  1. Dabholkar, M

    1. You have access
      Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
      M N Benchekroun, R Parker, M Dabholkar, E Reed and B K Sinha
      Molecular Pharmacology June 1995, 47 (6) 1255-1260;
  2. Danesi, R

    1. You have access
      Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells.
      R Danesi, W D Figg, E Reed and C E Myers
      Molecular Pharmacology June 1995, 47 (6) 1106-1111;
  3. Dean, G E

    1. You have access
      Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;
  4. Depoortere, H

    1. You have access
      Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;
  5. Dytko, G

    1. You have access
      Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;

E

  1. Erneux, C

    1. You have access
      2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
      R A Wilcox, C Erneux, W U Primrose, R Gigg and S R Nahorski
      Molecular Pharmacology June 1995, 47 (6) 1204-1211;
  2. Evans, W E

    1. You have access
      Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
      E Y Krynetski, N F Krynetskaia, Y Yanishevski and W E Evans
      Molecular Pharmacology June 1995, 47 (6) 1141-1147;

F

  1. Fagni, L

    1. You have access
      Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells.
      L Fagni, M Olivier, M Lafon-Cazal and J Bockaert
      Molecular Pharmacology June 1995, 47 (6) 1239-1247;
  2. Faure, C

    1. You have access
      Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;
  3. Ferrendelli, J A

    1. You have access
      Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;
  4. Figg, W D

    1. You have access
      Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells.
      R Danesi, W D Figg, E Reed and C E Myers
      Molecular Pharmacology June 1995, 47 (6) 1106-1111;
  5. Focher, F

    1. You have access
      5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;
  6. Freeman, L C

    1. You have access
      Cholinergic inhibition of slow delayed-rectifier K+ current in guinea pig sino-atrial node is not mediated by muscarinic receptors.
      L C Freeman and R S Kass
      Molecular Pharmacology June 1995, 47 (6) 1248-1254;

G

  1. Garbesi, A

    1. You have access
      5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;
  2. Ghadge, G D

    1. You have access
      Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;
  3. Gigg, R

    1. You have access
      2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
      R A Wilcox, C Erneux, W U Primrose, R Gigg and S R Nahorski
      Molecular Pharmacology June 1995, 47 (6) 1204-1211;
  4. Graham, D

    1. You have access
      Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;
  5. Grandy, D K

    1. You have access
      Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.
      S A Hjorth, K Thirstrup, D K Grandy and T W Schwartz
      Molecular Pharmacology June 1995, 47 (6) 1089-1094;
  6. Granger, P

    1. You have access
      Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;
  7. Green, M D

    1. You have access
      Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
      B L Coffman, M D Green, C D King and T R Tephly
      Molecular Pharmacology June 1995, 47 (6) 1101-1105;
  8. Guggino, W B

    1. You have access
      Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore.
      X J Li, R H Xu, W B Guggino and S H Snyder
      Molecular Pharmacology June 1995, 47 (6) 1133-1140;
  9. Gustafsson, J A

    1. You have access
      Cytochromes P450 of the 2D subfamily in rat brain.
      A Wyss, J A Gustafsson and M Warner
      Molecular Pharmacology June 1995, 47 (6) 1148-1155;

H

  1. Hamacher, L

    1. You have access
      Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
      M W Verghese, R T McConnell, J M Lenhard, L Hamacher and S L Jin
      Molecular Pharmacology June 1995, 47 (6) 1164-1171;
  2. Hansen, K R

    1. You have access
      Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;
  3. Hersh, L B

    1. You have access
      Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;
  4. Hjorth, S A

    1. You have access
      Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.
      S A Hjorth, K Thirstrup, D K Grandy and T W Schwartz
      Molecular Pharmacology June 1995, 47 (6) 1089-1094;
  5. Holland, K D

    1. You have access
      Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;

I

  1. Iafrate, E

    1. You have access
      5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;

J

  1. Jacobson, E

    1. You have access
      Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;
  2. Jin, S L

    1. You have access
      Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
      M W Verghese, R T McConnell, J M Lenhard, L Hamacher and S L Jin
      Molecular Pharmacology June 1995, 47 (6) 1164-1171;
  3. Jordan, J

    1. You have access
      Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;

K

  1. Kass, R S

    1. You have access
      Cholinergic inhibition of slow delayed-rectifier K+ current in guinea pig sino-atrial node is not mediated by muscarinic receptors.
      L C Freeman and R S Kass
      Molecular Pharmacology June 1995, 47 (6) 1248-1254;
  2. King, C D

    1. You have access
      Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
      B L Coffman, M D Green, C D King and T R Tephly
      Molecular Pharmacology June 1995, 47 (6) 1101-1105;
  3. Knepel, W

    1. You have access
      Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.
      M Schwaninger, C Schöfl, R Blume, L Rössig and W Knepel
      Molecular Pharmacology June 1995, 47 (6) 1112-1118;
  4. Knudsen, T B

    1. You have access
      Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;
  5. Krynetskaia, N F

    1. You have access
      Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
      E Y Krynetski, N F Krynetskaia, Y Yanishevski and W E Evans
      Molecular Pharmacology June 1995, 47 (6) 1141-1147;
  6. Krynetski, E Y

    1. You have access
      Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
      E Y Krynetski, N F Krynetskaia, Y Yanishevski and W E Evans
      Molecular Pharmacology June 1995, 47 (6) 1141-1147;

L

  1. Lafon-Cazal, M

    1. You have access
      Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells.
      L Fagni, M Olivier, M Lafon-Cazal and J Bockaert
      Molecular Pharmacology June 1995, 47 (6) 1239-1247;
  2. Langer, S Z

    1. You have access
      Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;
  3. Laurent, A B

    1. You have access
      Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;
  4. Lenhard, J M

    1. You have access
      Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
      M W Verghese, R T McConnell, J M Lenhard, L Hamacher and S L Jin
      Molecular Pharmacology June 1995, 47 (6) 1164-1171;
  5. Lerea, L S

    1. You have access
      N-methyl-D-aspartate receptors activate transcription of c-fos and NGFI-A by distinct phospholipase A2-requiring intracellular signaling pathways.
      L S Lerea, N G Carlson and J O McNamara
      Molecular Pharmacology June 1995, 47 (6) 1119-1125;
  6. Li, X J

    1. You have access
      Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore.
      X J Li, R H Xu, W B Guggino and S H Snyder
      Molecular Pharmacology June 1995, 47 (6) 1133-1140;

M

  1. Madara, J L

    1. You have access
      Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;
  2. Maga, G

    1. You have access
      5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;
  3. Makhlouf, G M

    1. You have access
      Adenosine A1 receptor-mediated activation of phospholipase C-beta 3 in intestinal muscle: dual requirement for alpha and beta gamma subunits of Gi3.
      K S Murthy and G M Makhlouf
      Molecular Pharmacology June 1995, 47 (6) 1172-1179;
  4. Manzini, S

    1. You have access
      5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;
  5. Mathews, G C

    1. You have access
      Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;
  6. McCay, P B

    1. You have access
      Metabolism of ethanol to 1-hydroxyethyl radicals in vivo: detection with intravenous administration of alpha-(4-pyridyl-1-oxide)-N-t-butylnitrone.
      D R Moore, L A Reinke and P B McCay
      Molecular Pharmacology June 1995, 47 (6) 1224-1230;
  7. McConnell, R T

    1. You have access
      Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
      M W Verghese, R T McConnell, J M Lenhard, L Hamacher and S L Jin
      Molecular Pharmacology June 1995, 47 (6) 1164-1171;
  8. McNamara, J O

    1. You have access
      N-methyl-D-aspartate receptors activate transcription of c-fos and NGFI-A by distinct phospholipase A2-requiring intracellular signaling pathways.
      L S Lerea, N G Carlson and J O McNamara
      Molecular Pharmacology June 1995, 47 (6) 1119-1125;
  9. Miller, R J

    1. You have access
      Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;
  10. Moore, D R

    1. You have access
      Metabolism of ethanol to 1-hydroxyethyl radicals in vivo: detection with intravenous administration of alpha-(4-pyridyl-1-oxide)-N-t-butylnitrone.
      D R Moore, L A Reinke and P B McCay
      Molecular Pharmacology June 1995, 47 (6) 1224-1230;
  11. Murthy, K S

    1. You have access
      Adenosine A1 receptor-mediated activation of phospholipase C-beta 3 in intestinal muscle: dual requirement for alpha and beta gamma subunits of Gi3.
      K S Murthy and G M Makhlouf
      Molecular Pharmacology June 1995, 47 (6) 1172-1179;
  12. Myers, C E

    1. You have access
      Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells.
      R Danesi, W D Figg, E Reed and C E Myers
      Molecular Pharmacology June 1995, 47 (6) 1106-1111;

N

  1. Nahorski, S R

    1. You have access
      2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
      R A Wilcox, C Erneux, W U Primrose, R Gigg and S R Nahorski
      Molecular Pharmacology June 1995, 47 (6) 1204-1211;
  2. Nambi, P

    1. You have access
      Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;

O

  1. Olivier, M

    1. You have access
      Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells.
      L Fagni, M Olivier, M Lafon-Cazal and J Bockaert
      Molecular Pharmacology June 1995, 47 (6) 1239-1247;

P

  1. Pan, Y X

    1. You have access
      Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;
  2. Parker, R

    1. You have access
      Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
      M N Benchekroun, R Parker, M Dabholkar, E Reed and B K Sinha
      Molecular Pharmacology June 1995, 47 (6) 1255-1260;
  3. Pasternak, G W

    1. You have access
      Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;
  4. Prehn, J H

    1. You have access
      Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;
  5. Primrose, W U

    1. You have access
      2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
      R A Wilcox, C Erneux, W U Primrose, R Gigg and S R Nahorski
      Molecular Pharmacology June 1995, 47 (6) 1204-1211;
  6. Puffinbarger, N K

    1. You have access
      Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;
  7. Pullen, M

    1. You have access
      Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;

R

  1. Reddy, P A

    1. You have access
      Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;
  2. Reed, E

    1. You have access
      Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells.
      R Danesi, W D Figg, E Reed and C E Myers
      Molecular Pharmacology June 1995, 47 (6) 1106-1111;
    2. You have access
      Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
      M N Benchekroun, R Parker, M Dabholkar, E Reed and B K Sinha
      Molecular Pharmacology June 1995, 47 (6) 1255-1260;
  3. Reinke, L A

    1. You have access
      Metabolism of ethanol to 1-hydroxyethyl radicals in vivo: detection with intravenous administration of alpha-(4-pyridyl-1-oxide)-N-t-butylnitrone.
      D R Moore, L A Reinke and P B McCay
      Molecular Pharmacology June 1995, 47 (6) 1224-1230;
  4. Resta, R

    1. You have access
      Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;
  5. Roos, R P

    1. You have access
      Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;
  6. Rossi, G

    1. You have access
      Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;
  7. Rössig, L

    1. You have access
      Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.
      M Schwaninger, C Schöfl, R Blume, L Rössig and W Knepel
      Molecular Pharmacology June 1995, 47 (6) 1112-1118;
  8. Rothman, S M

    1. You have access
      Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;
  9. Ryan-Moro, J

    1. You have access
      Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;

S

  1. Safayhi, H

    1. You have access
      Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
      H Safayhi, E R Sailer and H P Ammon
      Molecular Pharmacology June 1995, 47 (6) 1212-1216;
  2. Sailer, E R

    1. You have access
      Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
      H Safayhi, E R Sailer and H P Ammon
      Molecular Pharmacology June 1995, 47 (6) 1212-1216;
  3. Scatton, B

    1. You have access
      Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;
  4. Schöfl, C

    1. You have access
      Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.
      M Schwaninger, C Schöfl, R Blume, L Rössig and W Knepel
      Molecular Pharmacology June 1995, 47 (6) 1112-1118;
  5. Schwaninger, M

    1. You have access
      Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.
      M Schwaninger, C Schöfl, R Blume, L Rössig and W Knepel
      Molecular Pharmacology June 1995, 47 (6) 1112-1118;
  6. Schwartz, T W

    1. You have access
      Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.
      S A Hjorth, K Thirstrup, D K Grandy and T W Schwartz
      Molecular Pharmacology June 1995, 47 (6) 1089-1094;
  7. Sinha, B K

    1. You have access
      Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
      M N Benchekroun, R Parker, M Dabholkar, E Reed and B K Sinha
      Molecular Pharmacology June 1995, 47 (6) 1255-1260;
  8. Snyder, S H

    1. You have access
      Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore.
      X J Li, R H Xu, W B Guggino and S H Snyder
      Molecular Pharmacology June 1995, 47 (6) 1133-1140;
  9. Spadari, S

    1. You have access
      5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;
  10. Standifer, K M

    1. You have access
      Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;
  11. Swillens, S

    1. You have access
      Interpretation of binding curves obtained with high receptor concentrations: practical aid for computer analysis.
      S Swillens
      Molecular Pharmacology June 1995, 47 (6) 1197-1203;

T

  1. Tephly, T R

    1. You have access
      Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
      B L Coffman, M D Green, C D King and T R Tephly
      Molecular Pharmacology June 1995, 47 (6) 1101-1105;
  2. Thirstrup, K

    1. You have access
      Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.
      S A Hjorth, K Thirstrup, D K Grandy and T W Schwartz
      Molecular Pharmacology June 1995, 47 (6) 1089-1094;
  3. Thompson, L F

    1. You have access
      Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
      N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
      Molecular Pharmacology June 1995, 47 (6) 1126-1132;
  4. Tondelli, L

    1. You have access
      5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;
  5. Toth, P T

    1. You have access
      Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
      J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
      Molecular Pharmacology June 1995, 47 (6) 1095-1100;
  6. Tucker, J B

    1. You have access
      Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
      K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
      Molecular Pharmacology June 1995, 47 (6) 1217-1223;

V

  1. Verghese, M W

    1. You have access
      Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
      M W Verghese, R T McConnell, J M Lenhard, L Hamacher and S L Jin
      Molecular Pharmacology June 1995, 47 (6) 1164-1171;
  2. Verri, A

    1. You have access
      5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
      S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
      Molecular Pharmacology June 1995, 47 (6) 1231-1238;
  3. Vige, X

    1. You have access
      Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
      P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
      Molecular Pharmacology June 1995, 47 (6) 1189-1196;

W

  1. Warner, M

    1. You have access
      Cytochromes P450 of the 2D subfamily in rat brain.
      A Wyss, J A Gustafsson and M Warner
      Molecular Pharmacology June 1995, 47 (6) 1148-1155;
  2. Wilcox, R A

    1. You have access
      2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
      R A Wilcox, C Erneux, W U Primrose, R Gigg and S R Nahorski
      Molecular Pharmacology June 1995, 47 (6) 1204-1211;
  3. Wu, H L

    1. You have access
      Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
      C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
      Molecular Pharmacology June 1995, 47 (6) 1156-1163;
  4. Wyss, A

    1. You have access
      Cytochromes P450 of the 2D subfamily in rat brain.
      A Wyss, J A Gustafsson and M Warner
      Molecular Pharmacology June 1995, 47 (6) 1148-1155;

X

  1. Xu, J

    1. You have access
      Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
      Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
      Molecular Pharmacology June 1995, 47 (6) 1180-1188;
  2. Xu, R H

    1. You have access
      Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore.
      X J Li, R H Xu, W B Guggino and S H Snyder
      Molecular Pharmacology June 1995, 47 (6) 1133-1140;

Y

  1. Yanishevski, Y

    1. You have access
      Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
      E Y Krynetski, N F Krynetskaia, Y Yanishevski and W E Evans
      Molecular Pharmacology June 1995, 47 (6) 1141-1147;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 47, Issue 6
1 Jun 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics